Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by Haidukon Mar 04, 2015 3:24am
195 Views
Post# 23487197

Exercise of Warrants? On-going….

Exercise of Warrants? On-going….Overview limited to Insider Transactions with a first deadline for March 5, 2015:

Expiry Data Exercise Price Number of Warrants
March 5, 2015 0.15 14,844,200
May 3, 2015 0.15 3,790,000
September 19, 2015 0.16 10,054,274
October 23, 2015 0.20 10,215,000
March 6, 2017 0.20 9,245,790
Note – BIO Europe 2015

With “the glycoprotein program for anti-aging and regenerative medicine”, SBM is targeting not only the cosmetics market but also cell preservation (Cincinnati Children’s Hospital Medical Center + Biogalenys), vaccine preservation, organ transplant (longer preservation), etc.

This has a tremendous potential… if successful… and might take some time to market… but less to license/partnership.

Haiduk

PS: to jewel9m – thanks for your correction on my previous post.

Bullboard Posts